nach oben

Endocrine

Erschienen in:

02.07.2018 | Endocrine Surgery

Sentinel lymph node biopsy in small papillary thyroid cancer. A review on novel surgical techniques

verfasst von: Ludovico Maria Garau, Domenico Rubello, Alice Ferretti, Giuseppe Boni, Duccio Volterrani, Gianpiero Manca

Erschienen in: Endocrine | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Sentinel lymph node biopsy (SNB) in patients with papillary thyroid carcinoma (PTC) and negative for clinically neck lymph node metastatic involvement (N0) has emerged as a promising minimally invasive procedure to detect metastatic nodes.

Methods

The MEDLINE database was searched via the PubMed interface on 10 January 2018 for the MeSH headings “sentinel lymph node biopsy” and “thyroid carcinoma”.

Results

Vital blue dye, radioisotope, and the combination of both techniques are used in PTC patients. These methods and the emerging role of SPECT/CT are discussed in this review. The sentinel lymph node (SLN) identification rates ranged from 0 to 100% for blue dye, 83 to 100% for radioisotopes, and 66 to 100% for the combination of both techniques, respectively.

Conclusions

SNB based on radioisotope technique with the use of intraoperative gamma-probe is an accurate and safe method that allows the highest SLN detection rate. There is sufficient evidence to propagate the increasing use of SNB procedure that has the potential to avoid prophylactic lymph node surgery in patients clinically N0.

H. Salvesen, P.R. Njølstad, L.A. Akslen, G. Albrektsen, O. Søreide, J.E. Varhaug, Papillary thyroid carcinoma: a multivariate analysis of prognostic factors including an evaluation of the p-TNM staging system. Eur. J. Surg. 158, 583–589 (1992)PubMed

T. Mijovic, Sentinel lymph node biopsy in well differentiated thyroid carcinoma. Update Underst. Manag. Thyroid Cancer 32, 782–785 (2012)

S.M. Wiseman, W.L. Hicks, Q.D. Chu, N.R. Rigual, Sentinel lymph node biopsy in staging of differentiated thyroid cancer: a critical review. Surg. Oncol. 11, 137–142 (2002)CrossRefPubMed

S.J. Stoeckli, M. Pfaltz, H. Steinert, S. Schmid, Sentinel lymph node biopsy in thyroid tumors: a pilot study. Eur. Arch. Oto-Rhino-Laryngol. 260, 364–368 (2003). https://doi.org/10.1007/s00405-003-0594-y CrossRef

G.M. Salvatori, D. Rubello, Sentinel lymph node biopsy in papillary thyroid cancer. Radio. Surg. 32, 782–785 (2008)

D. Rubello, M.R. Pelizzo, A. Al-Nahhas, M. Salvatori, M.J. O’Doherty, A.E. Giuliano, M.D. Gross, S. Fanti, S. Sandrucci, D. Casara, G. Mariani, The role of sentinel lymph node biopsy in patients with differentiated thyroid carcinoma. Eur. J. Surg. Oncol. 32, 917–921 (2006). https://doi.org/10.1016/j.ejso.2006.03.018 CrossRefPubMed

I.M. Boschin, M.R. Pelizzo, F. Giammarile, D. Rubello, P.M. Collett, Lymphoscintigraphy in differentiated thyroid cancer. Clin. Nucl. Med. 40, e343–350 (2015). https://doi.org/10.1097/RLU.0000000000000825 CrossRefPubMed

A. Machens, R. Hinze, O. Thomusch, H. Dralle, Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J. Surg. 26, 22–28 (2002). https://doi.org/10.1007/s00268-001-0176-3 CrossRefPubMed

M.E. Kupferman, M. Patterson, S.J. Mandel, S.J. Mandel, V. LiVolsi, R.S. Weber, Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch. Otolaryngol. Neck Surg. 130, 857 (2004). https://doi.org/10.1001/archotol.130.7.857 CrossRef

10.

A. Machens, H. Dralle, Prediction of mediastinal lymph node metastasis in papillary thyroid cancer. Ann. Surg. Oncol. 16, 171–176 (2009). https://doi.org/10.1245/s10434-008-0201-y CrossRefPubMed

11.

D. Fritze, G.M. Doherty, Surgical management of cervical lymph nodes in differentiated thyroid cancer. Otolaryngol. Clin. North. Am. 43, 285–300 (2010). https://doi.org/10.1016/j.otc.2010.01.005 CrossRefPubMed

12.

Y. Ito, C. Tomoda, T. Uruno, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J. Surg. 30, 91–99 (2006). https://doi.org/10.1007/s00268-005-0113-y CrossRefPubMed

13.

I. Sugitani, N. Kasai, Y. Fujimoto, A. Yanagisawa, A novel classification system for patients with PTC: addition of the new variables of large (3cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135, 139–148 (2004). https://doi.org/10.1016/S0039 CrossRefPubMed

14.

C.R. McHenry, I.B. Rosen, P.G. Walfish, Prospective management of nodal metastases in differentiated thyroid cancer. Am. J. Surg. 162, 353–356 (1991)CrossRefPubMed

15.

Y. Ito, T. Higashiyama, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: Validity of prophylactic modified radical neck dissection. World J. Surg. 31, 2085–2091 (2007). https://doi.org/10.1007/s00268-007-9224-y CrossRefPubMed

16.

G.W. Randolph, Q.-Y. Duh, K.S. Heller, V.A. LiVolsi, S.J. Mandel, D.L. Steward, R.P. Tufano, R.M. Tuttle; American Thyroid Association Surgical Affairs Committee’s Taskforce on Thyroid Cancer Nodal Surgery., The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22, 1144–1152 (2012). https://doi.org/10.1089/thy.2012.0043 CrossRefPubMed

17.

S. Leboulleux, C. Rubino, E. Baudin, B. Caillou, D.M. Hartl, J.M. Bidart, J.P. Travagli, M. Schlumberger, Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J. Clin. Endocrinol. Metab. 90, 5723–5729 (2005). https://doi.org/10.1210/jc.2005-0285 CrossRefPubMed

18.

G.H. Sakorafas, D. Sampanis, M. Safioleas, Cervical lymph node dissection in papillary thyroid cancer: Current trends, persisting controversies, and unclarified uncertainties. Surg. Oncol. 19, e57–e70 (2010). https://doi.org/10.1016/j.suronc.2009.04.002 CrossRefPubMed

19.

Y.C. Lee, S.Y. Na, G.C. Park, J.H. Han, S.W. Kim, Y.G. Eun, Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study. Surgery 161, 465–258 (2017). https://doi.org/10.1016/j.surg.2016.07.031 CrossRefPubMed

20.

V. Zaydfudim, I.D. Feurer, M.R. Griffin, J.E. Phay, The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144, 1070–1078 (2008). https://doi.org/10.1016/j.surg.2008.08.034 CrossRefPubMed

21.

M.A. Adam, J. Pura, P. Goffredo, M.A. Dinan, S.D. Reed, R.P. Scheri, T. Hyslop, S.A. Roman, J.A. Sosa, Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer. J. Clin. Oncol. 33, 2370–2375 (2015). https://doi.org/10.1200/JCO.2014.59.8391 CrossRefPubMed

22.

C. De Crea, M. Raffaelli, L. Sessa, C.P. Lombardi, R. Bellantone, Surgical approach to level VI in papillary thyroid carcinoma: an overview. Updates Surg. 69, 205–209 (2017). https://doi.org/10.1007/s13304-017-0468-2 CrossRefPubMed

23.

I.J. Nixon, A.R. Shaha, Management of regional nodes in thyroid cancer. Oral Oncol. 49, 671–675 (2013). https://doi.org/10.1016/j.oraloncology.2013.03.441. CrossRefPubMed

24.

B.R. Haugen, E.K. Alexander., K.C. Bible et al.. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26, 1–133 (2016). https://doi.org/10.1089/thy.2015.0020 CrossRefPubMedPubMedCentral

25.

Y.B. Ji, D.W. Lee, C.M. Song, K.R. Kim, C.W. Park, K. Tae, Accuracy of intraoperative determination of central node metastasis by the surgeon in papillary thyroid carcinoma. Otolaryngol. Head. Neck. Surg. 150(4), 542–547 (2014). https://doi.org/10.1177/0194599813519405. AprCrossRefPubMed

26.

J. Liang, Z. Li, F. Fang, T. Yu, S. Li, Is prophylactic central neck dissection necessary for cN0 differentiated thyroid cancer patients at initial treatment? A meta-analysis of the literature. Acta Otorhinolaryngol. Ital. 37, 1–8 (2017). https://doi.org/10.14639/0392-100x-1195 CrossRefPubMedPubMedCentral

27.

G.F. Scheumann, H. Seeliger, T.J. Musholt, O. Gimm, G. Wegener, H. Dralle, H. Hundeshagen, R. Pichlmayr, Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur. J. Surg. 162, 677–684 (1996)PubMed

28.

S.K. Kim, J.W. Woo, J.H. Lee, I. Park, J.H. Choe, J.H. Kim, J.S. Kim, Prophylactic central neck dissection might not be necessary in papillary thyroid carcinoma: analysis of 11,569 Cases from a single institution. J. Am. Coll. Surg. 222, 853–864 (2016). https://doi.org/10.1016/j.jamcollsurg.2016.02.001 CrossRefPubMed

29.

J.F. Henry, L. Gramatica, A. Denizot, A. Kvachenyuk, M. Puccini, T. Defechereux, Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbeck’s Arch. Surg. 383, 167–169 (1998)

30.

T.S. Wang, D.B. Evans, G.G. Fareau, T. Carroll, T.W. Yen, Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer. Ann. Surg. Oncol. 19, 4217–4222 (2012). https://doi.org/10.1245/s10434-012-2594-x CrossRefPubMed

31.

P.R. Kelemen, A.J. Van Herle, A.E. Giuliano, Sentinel lymphadenectomy in thyroid malignant neoplasms. Arch. Surg. 133, 288–292 (1998)CrossRefPubMed

32.

L. Falvo, A. Marzullo, S. Palermo, A. Biancafarina, M. De Stefano, B. Vanni, S. Sorrenti, A. Catania, The sentinel lymph node in papillary cancer of the thyroid including histological subtype. Ann. Ital. Chir. 77, 13–18 (2006)PubMed

33.

R. Dzodic, I. Markovic, M. Inic, N. Jokic, I. Djurisic, M. Zegarac, G. Pupic, Z. Milovanovic, V. Jovic, N. Jovanovic, Sentinel lymph node biopsy may be used to support the decision to perform modified radical neck dissection in differentiated thyroid carcinoma. World J. Surg. 30, 841–846 (2006). https://doi.org/10.1007/s00268-005-0298-0 CrossRefPubMed

34.

J.L. Roh, W.M. Koch, Role of sentinel lymph node biopsy in thyroid cancer. Expert. Rev. AntiCancer Ther. 10, 1429–1437 (2010). https://doi.org/10.1586/era.10.111 CrossRefPubMed

35.

H. Takeyama, I. Tabei, K. Uchida, T. Morikawa, Sentinel node biopsy for follicular tumours of the thyroid gland. Br. J. Surg. 96, 490–495 (2009). https://doi.org/10.1002/bjs.6559 CrossRefPubMed

36.

S.K. Lee, J.H. Choi, H.I. Lim, W.W. Kim, S.M. Kim, J.H. Choe, J.E. Lee, J.H. Shin, J.Y. Choi, J.H. Kim, J.S. Kim, S.J. Nam, J.H. Yang, Sentinel lymph node biopsy in papillary thyroid cancer: comparison study of blue dye method and combined radioisotope and blue dye method in papillary thyroid cancer. Eur. J. Surg. Oncol. 35, 974–979 (2009). https://doi.org/10.1016/j.ejso.2009.02.008 CrossRefPubMed

37.

Y.B. Ji, K.J. Lee, Y.S. Park, S.M. Hong, S.S. Paik, K. Tae, Clinical efficacy of sentinel lymph node biopsy using methylene blue dye in clinically node-negative papillary thyroid carcinoma. Ann. Surg. Oncol. 19, 1868–1873 (2012). https://doi.org/10.1245/s10434-011-2109-1 CrossRefPubMed

38.

D.K. Cunningham, K.A. Yao, R.R. Turner, F.R. Singer, A.R. Van Herle, A.E. Giuliano, Sentinel lymph node biopsy for papillary thyroid cancer: 12 years of experience at a single institution. Ann. Surg. Oncol. 17, 2970–2975 (2010). https://doi.org/10.1245/s10434-010-1141-x CrossRefPubMed

39.

O. Huang, W. Wu, O. Wang et al.. Sentinel lymph node biopsy is unsuitable for routine practice in younger female patients with unilateral low-risk papillary thyroid carcinoma. BMC Cancer 11, 386 (2011). https://doi.org/10.1186/1471-2407-11-386 CrossRefPubMedPubMedCentral

40.

S.M. Anand, O. Gologan, L. Rochon, M. Tamilia, J. How, M.P. Hier, M.J. Black, K. Richardson, H.A. Hakami, H.Z. Marzouki, M. Trifiro, R. Tabah, R.J. Payne, The role of sentinel lymph node biopsy in differentiated thyroid carcinoma. Arch. Otolaryngol. Head Neck Surg. 135(12), 1199–1204 (2009)CrossRefPubMed

41.

R.T.T. Hao, J. Chen, L.H.H. Zhao, C. Liu, O.C. Wang, G.L. Huang, X.H. Zhang, J. Zhao, Sentinel lymph node biopsy using carbon nanoparticles for Chinese patients with papillary thyroid microcarcinoma. Eur. J. Surg. Oncol. 38, 718–724 (2012). https://doi.org/10.1016/j.ejso.2012.02.001 CrossRefPubMed

42.

E. Dixon, J.G. McKinnon, J.L. Pasieka, Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J. Surg. 24, 1396–1401 (2000)CrossRefPubMed

43.

A. Larrad Jimenez, P. de Quadros Borrajo, A. Martin Duce, Evaluation of the sentinel lymph node in T1-T2 papillary thyroid cancer: a preliminary study. Cir. Esp. 90, 440–445 (2012). https://doi.org/10.1016/j.ciresp.2012.02.007 CrossRefPubMed

44.

X. Li, H. Ma, X. Tian, X. Jin, Elective neck dissection in papillary thyroid carcinoma patients. Acta Chir. Belg. 112, 44–50 (2012)CrossRefPubMed

45.

Y. Jozaghi, K. Richardson, S. Anand, A. Mlynarek, M.P. Hier, V.I. Forest, E. Sela, M. Tamilia, D. Caglar, R.J. Payne, Frozen section analysis and sentinel lymph node biopsy in well differentiated thyroid cancer. J. Otolaryngol. Head. Neck Surg. 42, 48 (2013). https://doi.org/10.1186/1916-0216-42-48 CrossRefPubMedPubMedCentral

46.

K. Kaczka, B. Luks, J. Jasion, L. Pomorski, Sentinel lymph node in thyroid tumors - own experience. Contemp. Oncol. (Pozn., Pol.) 17, 184–189 (2013). https://doi.org/10.5114/wo.2013.34623 CrossRef

47.

E.-S. Abd-Elwahab, H.-E. El-hady, O.-E. Khaled, Sentinel lymph node biopsy using blue dye as guidance for central neck dissection in patients with clinically node-negative papillary thyroid carcinoma. Tanta Med. J. 42, 58 (2014). https://doi.org/10.4103/1110-1415.137803 CrossRef

48.

Y. Fukui, T. Yamakawa, T. Taniki, S. Numoto, H. Miki, Y. Monden, Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 92, 2868–2874 (2001)CrossRefPubMed

49.

J. Arch-Ferrer, D. Velázquez, R. Fajardo, A. Gamboa-Domínguez, M.F. Herrera, Accuracy of sentinel lymph node in papillary thyroid carcinoma. Surgery 130, 907–913 (2001). https://doi.org/10.1067/msy.2001.118372 CrossRefPubMed

50.

K. Tsugawa, I. Ohnishi, M. Nakamura, K. Miwa, K. Yokoyama, T. Michigishi, M. Noguchi, A. Nonomura, Intraoperative lymphatic mapping and sentinel lymph node biopsy in patients with papillary carcinoma of the thyroid gland. Biomed. Pharmacother. 56(Suppl 1), 100s–103s (2002)CrossRefPubMed

51.

H. Takami, Y. Ikeda, G. Tajima, G. Tajima, K. Kameyama, Detection of sentinel lymph nodes in patients with papillary thyroid cancer. Asian J. Surg. 26, 145–148 (2003). https://doi.org/10.1016/S1015-9584(09)60373-0 CrossRefPubMed

52.

T.-L. Chow, B.-H. Lim, S.P.-Y. Kwok, Sentinel lymph node dissection in papillary thyroid carcinoma. Anz. J. Surg. 74, 10–12 (2004)CrossRefPubMed

53.

D. Rubello, C. Nanni, I. Merante Boschin, A. Toniato, A. Piotto, L. Rampin, G. Mariani, A. Al-Nahhas, M.R. Pelizzo, Sentinel lymph node (SLN) procedure with patent V blue dye in 153 patients with papillary thyroid carcinoma (PTC): is it an accurate staging method? J. Exp. Clin. Cancer Res. 25, 483–486 (2006)PubMed

54.

N. Peparini, A. Maturo, F.M. Di Matteo, F. Tartaglia, M. Marchesi, E.P. Campana, Blue-dye sentinel node mapping in thyroid carcinoma: debatable results of feasibility. Acta Chir. Belg. 106, 523–527 (2006)CrossRefPubMed

55.

A. Garcia-Burillo, I. Roca Bielsa, O. Gonzalez, C. Zafon, M. Sabate, J. Castellvi, X. Serres, C. Iglesias, R. Vilallonga, E. Caubet, J.M. Fort, J. Mesa, M. Armengol, J. Castell-Conesa, SPECT/CT sentinel lymph node identification in papillary thyroid cancer: Lymphatic staging and surgical management improvement. Eur. J. Nucl. Med. Mol. Imaging 40, 1645–1655 (2013). https://doi.org/10.1007/s00259-013-2476-x CrossRefPubMed

56.

S.H. Paek, K.H. Yi, S.-J. Kim, J.Y. Choi, K.E. Lee, Y.J. Park, D.J. Park, K.W. Kang, J.K. Chung, Feasibility of sentinel lymph node dissection using Tc-99m phytate in papillary thyroid carcinoma. Ann. Surg. Treat. Res. 93, 240–245 (2017). https://doi.org/10.4174/astr.2017.93.5.240 CrossRefPubMedPubMedCentral

57.

R.N. Cabrera, C.T. Chone, D.E. Zantut-Wittmann, P.S. Matos, D.M. Ferreira, P.S. Pereira, M.P. Ribeiro, A.O. Santos, C.D. Ramos, A.N. Crespo, E.C. Etchebehere, The role of SPECT/CT lymphoscintigraphy and radioguided sentinel lymph node biopsy in managing papillary thyroid cancer. JAMA. Otolaryngol. Head Neck Surg. 142, 834–841 (2016). https://doi.org/10.1001/jamaoto.2016.1227 CrossRef

58.

J. Lee, K.Y. Na, J. Lee, S.J. Lee, Y.S. An, J.K. Yoon, E.Y. Soh, The usefulness and accuracy of sentinel lymph node biopsy using single photon emission computed tomography/computed tomography with 99mTc phytate to detect locoregional lymph node metastases in patients with papillary thyroid carcinoma. J. Korean Surg. Soc. 84, 195–201 (2013). https://doi.org/10.4174/jkss.2013.84.4.195 CrossRefPubMedPubMedCentral

59.

G. Manca, D. Volterrani, S. Mazzarri, V. Duce, A. Svirydenka, A. Giuliano, G. Mariani, Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue. Q. J. Nucl. Med. Mol. Imaging 58, 114–126 (2014)PubMed

60.

H.J. Gallowitsch, P. Mikosch, E. Kresnik, M. Starlinger, P. Lind, Lymphoscintigraphy and gamma probe-guided surgery in papillary thyroid carcinoma: the sentinel lymph node concept in thyroid carcinoma. Clin. Nucl. Med. 24, 744–746 (1999)CrossRefPubMed

61.

M. Catarci, F. Zaraca, R. Angeloni, B. Mancini, M.G. de Filippo, R. Massa, M. Carboni, G. Pasquini, Preoperative lymphoscintigraphy and sentinel lymph node biopsy in papillary thyroid cancer. A pilot study. J. Surg. Oncol. 77, 21–24 (2001)CrossRefPubMed

62.

M. Assadi, M. Yarani, S.R. Zakavi, A. Jangjoo, B. Memar, G. Treglia, M. Aliakbarian, M. Mehrabibahar, R. Sadeghi, SLN mapping in PTC using combined radiotracer and blue dye methods. Endokrynol. Pol. 65, 281–286 (2014). https://doi.org/10.5603/EP.2014.0038 CrossRefPubMed

63.

L.F. Chapman, Mechanisms of the flare reaction in human skin. J. Invest. Dermatol. 69(1), 88–97 (1977).CrossRefPubMed

64.

R. Gelmini, M. Campanelli, F. Cabry, A. Franceschetto, G. Ceresini, L. Ruffini, A. Zaccaroni, P. Del Rio, Role of sentinel node in differentiated thyroid cancer: a prospective study comparing patent blue injection technique, lymphoscintigraphy and the combined technique. J. Endocrinol. Invest. 41(3), 363–370 (2017). https://doi.org/10.1007/s40618-017-0756-1 CrossRefPubMed

65.

J.D. Wang, X.C. Deng, X.J. Jin, C. Zhang, J.Q. Zhou, Q.Y. Zhou, J. Liu, M.F. Qian, Surgical exploration of the sentinel lymph nodes in the papillary thyroid carcinoma. Rev. Laryngol. Otol. Rhinol. (Bord.) 129, 285–287 (2008)

66.

S.P. Balasubramanian, B.J. Harrison, Systematic review and meta-analysis of sentinel node biopsy in thyroid cancer. Br. J. Surg. 98, 334–344 (2011). https://doi.org/10.1002/bjs.7425 CrossRefPubMed

67.

J.S. Bae, W.C. Park, B.J. Song, S.S. Jung, J.S. Kim, Endoscopic thyroidectomy and sentinel lymph node biopsy via an anterior chest approach for papillary thyroid cancer. Surg. Today 39, 178–181 (2009). https://doi.org/10.1007/s00595-008-3840-5 CrossRefPubMed

68.

A. Amir, R. Payne, K. Richardson, M. Hier, A. Mlynarek, D. Caglar, Sentinel lymph node biopsy in thyroid cancer: it can work but there are pitfalls. Otolaryngol. Neck Surg. 145, 723–726 (2011). https://doi.org/10.1177/0194599811415809 CrossRef

69.

K. Kaczka, A. Celnik, B. Luks, J. Jasion, L. Pomorski, Sentinel lymph node biopsy techniques in thyroid pathologies--a meta-analysis. Endokrynol. Pol. 63, 222–321 (2012)PubMed

70.

P.G.H.M. Raijmakers, M.A. Paul, P. Lips, Sentinel node detection in patients with thyroid carcinoma: a meta-analysis. World J. Surg. 32, 1961–1967 (2008). https://doi.org/10.1007/s00268-008-9657-y CrossRefPubMedPubMedCentral

71.

S.P. Balasubramanian, J. Brignall, H.Y. Lin, T.J. Stephenson, J. Wadsley, B.J. Harrison, W.L. Craig, L. Smart, Z. Krukowski, Sentinel node biopsy in papillary thyroid cancer-what is the potential? Langenbeck’s Arch. Surg. 399, 245–251 (2014). https://doi.org/10.1007/s00423-014-1168-8 CrossRef

72.

I.M. Boschin, D. Rubello, C. Bluemel, K. Herrmann, M.R. Pelizzo, Radioguided sentinel lymph node mapping and biopsy in thyroid cancer. In: K. Herrmann, O.E. Nieweg, S.P. Povoski, (eds.) Radioguided Surgery: Current Applications and Innovative Directions in Clinical Practice, pp. 183–196. Springer, Cham: Switzerland (2016)CrossRef

73.

M. Goran, T. Pekmezovic, I. Markovic, N. Santrac, M. Buta, D. Gavrilovic, N. Besic, Y. Ito, I. Djurisic, G. Pupic, R. Dzodic, Lymph node metastases in clinically N0 patients with papillary thyroid microcarcinomas - a single institution experience. J. Buon. 22, 224–231 (2017)PubMed

74.

A.K. Buck, S. Nekolla, S. Ziegler, A. Beer, B.J. Krause, K. Herrmann, K. Scheidhauer, H.J. Wester, E.J. Rummeny, M. Schwaiger, A. Drzezga, Spect/Ct. J. Nucl. Med. 49, 1305–1319 (2008). https://doi.org/10.2967/jnumed.107.050195 CrossRefPubMed

75.

R.A. Valdés Olmos, D.D. Rietbergen, S. Vidal-Sicart, G. Manca, F. Giammarile, G. Mariani, Contribution of SPECT/CT imaging to radioguided sentinel lymph node biopsy in breast cancer, melanoma, and other solid cancers: from “open and see” to “see and open”. Q. J. Nucl. Med. Mol. Imaging 58, 127–39 (2014)PubMed

76.

J.P. Hoogendam, W.B. Veldhuis, M.G.G. Hobbelink, R.H. Verheijen, M.A. van den Bosch, R.P. Zweemer, 99mTc SPECT/CT versus planar lymphoscintigraphy for preoperative sentinel lymph node detection in cervical cancer: a systematic review and metaanalysis. J. Nucl. Med. 56, 675–680 (2015). https://doi.org/10.2967/jnumed.114.152439 CrossRefPubMed

77.

B.H. Hasegawa, K.H. Wong, K. Iwata, W.C. Barber, A.B. Hwang, A.E. Sakdinawat, M. Ramaswamy, D.C. Price, R.A. Hawkins, Dual-modality imaging of cancer with SPECT/CT. Technol. Cancer Res. Treat. 1, 449–458 (2002). https://doi.org/10.1177/153303460200100605 CrossRefPubMed

78.

G. Manca, S. Mazzarri, D. Rubello, E. Tardelli, R.C. Delgado-Bolton, F. Giammarile, M. Roncella, D. Volterrani, P.M. Colletti, Radioguided occult lesion localization. Clin. Nucl. Med. 00, 1 (2017)

79.

G. Manca, D. Rubello, A. Romanini, G. Boni, S. Chiacchio, M. Tredici, S. Mazzarri, V. Duce, P.M. Colletti, D. Volterrani, G. Mariani, Sentinel lymph node mapping in melanoma: the issue of false-negative findings. Clin. Nucl. Med. 39, 346–354 (2014). https://doi.org/10.1097/RLU.0000000000000366 CrossRef

80.

C.K.H. Wong, B.H.H. Lang, A cost-utility analysis for prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma. Ann. Surg. Oncol. 21, 767–777 (2014). https://doi.org/10.1245/s10434-013-3398-3 CrossRefPubMed

81.

F.F. Palazzo, J. Gosnell, R. Savio, T.S. Reeve, S.B. Sidhu, M.S. Sywak, B. Robinson, L.W. Delbridge, Lymphadenectomy for papillary thyroid cancer: Changes in practice over four decades. Eur. J. Surg. Oncol. 32, 340–344 (2006). https://doi.org/10.1016/j.ejso.2005.12.011 CrossRefPubMed

82.

P. Carcoforo, M. Portinari, L. Feggi, S. Panareo, A. De Troia, M.C. Zatelli, G. Trasforini, E. Degli Uberti, E. Forini, C.V. Feo, Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: A prospective study on 345 patients with a 3-year follow-up. Surgery (U. S.) 156, 147–157 (2014). https://doi.org/10.1016/j.surg.2014.03.045 CrossRef

83.

Y.S. Lee, S.W. Kim, S.W. Kim, S.K. Kim, H.S. Kang, E.S. Lee, K.W. Chung, Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J. Surg. 31, 1954–1959 (2007). https://doi.org/10.1007/s00268-007-9171-7 CrossRefPubMed

84.

O. González, C. Iglesias, C. Zafon, J. Castellví, A. García-Burillo, J. Temprana, E. Caubet, R. Vilallonga, J. Mesa, y Ramón, S. Cajal, J.M. Fort, M. Armengol, J.M. Balibrea, Detection of thyroid papillary carcinoma lymph node metastases using one step nucleic acid amplification (OSNA): Preliminary Results. J. Invest. Surg. 28, 153–9 (2015). https://doi.org/10.3109/08941939.2014.990123 CrossRefPubMed

85.

S. Fischer, S.L. Asa, Application of immunohistochemistry to thyroid neoplasms. Arch. Pathol. Lab. Med. 132, 359–372 (2008). https://doi.org/10.1043/1543-2165(2008)132[359:AOITTN]2.0.CO;2 CrossRefPubMed

86.

M.V. Pusic, K. Boutis, R. Hatala, D.A. Cook, Learning curves in health professions education. Acad. Med. 90(8), 1034–1042 (2015). https://doi.org/10.1097/ACM.000000000000681. AugCrossRefPubMed

87.

M.E. Valsecchi, D. Silbermins, N. De Rosa, S.L. Wong, G.H. Lyman, Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: A meta-analysis. J. Clin. Oncol. 29, 1479–1487 (2011). https://doi.org/10.1200/JCO.2010.33.1884 CrossRefPubMed

88.

P. Carcoforo, L. Feggi, G. Trasforini, S. Lanzara, D. Sortini, V. Zulian, G.C. Pansini, E. Degli Uberti, A. Liboni, Use of preoperative lymphoscintigraphy and intraoperative gamma-probe detection for identification of the sentinel lymph node in patients with papillary thyroid carcinoma. Eur. J. Surg. Oncol. 33, 1075–80 (2007). https://doi.org/10.1016/j.ejso.2007.01.025 CrossRefPubMed

89.

I.M. Boschin, A. Toniato, A. Piotto, E.C. Ide, D. Casara, A. Guolo, D. Rubello, M. Pelizzo, 99Tc Nanocolloid sentinel node procedure in thyroid carcinoma. Langenbeck’s Arch. Surg. 393, 705–708 (2008). https://doi.org/10.1007/s00423-008-0376-5 CrossRef

90.

M.R. Pelizzo, A. Toniato, N. Sorgato, A. Losi, F. Torresan, I. Merante Boschin, 99Tc nanocolloid sentinel node procedure in papillary thyroid carcinoma: our mono-institutional experience on a large series of patients. Acta Otorhinolaryngol. Ital. 29, 321–325 (2009)PubMedPubMedCentral

91.

D.Y. Lee, K.H. Oh, J.-G. Cho, S.Y. Kwon, J.S. Woo, S.K. Baek, K.Y. Jung, The benefits and risks of prophylactic central neck dissection for papillary thyroid carcinoma: prospective cohort study. Int. J. Endocrinol. 1–6 (2015). https://doi.org/10.1155/2015/571480

92.

J.L. Roh, C.I. Park, Sentinel lymph node biopsy as guidance for central neck dissection in patients with papillary thyroid carcinoma. Cancer 113, 1527–31 (2008). https://doi.org/10.1002/cncr.23779 CrossRefPubMed

93.

L. Rettenbacher, P. Sungler, D. Gmeiner, H. Kässmann, G. Galvan, Detecting the sentinel lymph node in patients with differentiated thyroid carcinoma. Eur. J. Nucl. Med. 27, 1399–401 (2000)CrossRefPubMed

94.

M.R. Pelizzo, I.M. Boschin, A. Toniato, A. Piotto, P. Bernante, C. Paggetta, G.L. De Salvo, A. Carpi, D. Rubello, D. Casara, Sentinel node mapping and biopsy in thyroid cancer: a surgical perspective. Biomed. Pharmacother. 60, 405–8 (2006). https://doi.org/10.1016/j.biopha.2006.08.001 CrossRefPubMed

95.

M.R. Pelizzo, D. Rubello, I.M. Boschin, A. Piotto, C. Paggetta, A. Toniato, G.L. De Salvo, A. Giuliano, G. Mariani, D. Casara, Contribution of SLN investigation with 99mTc-nanocolloid in clinical staging of thyroid cancer: technical feasibility. Eur. J. Nucl. Med. Mol. Imaging 34, 934–8 (2007). https://doi.org/10.1007/s00259-006-0316-y CrossRefPubMed

96.

S.K. Lee, S.H. Kim, S.M. Hur, J.H. Choe, J.H. Kim, J.S. Kim, The efficacy of lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma. World J. Surg. 35, 2675–2682 (2011). https://doi.org/10.1007/s00268-011-1254-9 CrossRefPubMed

97.

S.K. Lee, J.H. Lee, S.Y. Bae et al.. Lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma, is it really necessary? A randomized, controlled study. Surgery 157, 518–525 (2015). https://doi.org/10.1016/j.surg.2014.10.013 CrossRefPubMed

Titel: Sentinel lymph node biopsy in small papillary thyroid cancer. A review on novel surgical techniques
verfasst von: Ludovico Maria Garau
Domenico Rubello
Alice Ferretti
Giuseppe Boni
Duccio Volterrani
Gianpiero Manca
Publikationsdatum: 02.07.2018
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 2/2018
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-018-1658-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypertonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Sentinel lymph node biopsy in small papillary thyroid cancer. A review on novel surgical techniques

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

An assessment of the relationship between thyroid nodule characteristics, insulin resistance and arterial stiffness in euthyroid nodular goiter

Efficacy and safety of cooled and uncooled microwave ablation for the treatment of benign thyroid nodules: a systematic review and meta-analysis

New modified Friedewald formulae for estimating low-density lipoprotein cholesterol according to triglyceride levels: extraction and validation

Strategies to reduce readmissions for hyponatremia after transsphenoidal surgery for pituitary adenomas

Macroprolactinomas: longitudinal assessment of biochemical and imaging therapeutic responses

A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Metformin rückt in den Hintergrund

Update Innere Medizin